Hydration and fluids
Quick answer. Fluids matter on GLP-1 medicines mostly because vomiting, diarrhea and eating less can leave you short of fluid. Both the Wegovy and Zepbound labels warn that this can cause acute kidney injury. Expert groups say to prevent dehydration, but the sources the Atlas reviewed do not set a daily fluid target for these medicines, and no trial has tested electrolyte drinks.
Why fluids matter on these medicines
Feeling full makes some people drink less. A 2023 expert consensus notes that the sense of fullness after a dose leads many people to cut back on water, and that this can feed into constipation. On top of that, nausea, vomiting and diarrhea all drain fluid.
Dehydration is not only about feeling thirsty. Your kidneys depend on enough blood volume, which is why the official labels treat fluid loss as a kidney safety issue and not just a comfort one.
This page covers what the labels and expert groups say. It does not give a number of cups, because the sources do not.
What the labels and trials show
The current Wegovy and Zepbound labels both carry a warning about acute kidney injury. The Zepbound label notes that postmarketing reports were mostly preceded by digestive reactions that led to dehydration, and some cases needed dialysis. Both labels tell prescribers to monitor kidney function in people reporting side effects that could cause fluid loss. Postmarketing reports come from people who chose to report, so they cannot give a rate.
The trials counted digestive side effects but did not test how much people should drink. The Atlas did not find a randomized trial of a fluid target, hydration drink or electrolyte supplement in people taking these medicines.
What experts say about fluids
The 2025 advisory says dehydration from severe nausea, vomiting or diarrhea can cause acute kidney injury, in people with or without existing kidney disease, and can also cause heart palpitations. It says efforts should be made to prevent it. People who have or are at risk for kidney problems should be counseled on preventing dehydration and have their kidney function monitored, since post-market reports describe kidney problems at the start of treatment and at dose increases.
The advisory also stresses adequate fluids together with fiber from food for constipation, and drinking enough while eating small meals through a bout of nausea. It suggests that smoothies, protein drinks made with unsweetened milks or yogurt, and soups can supply nutrients when appetite is low. It advises people to avoid sugar-sweetened beverages as part of overall diet quality.
The 2023 consensus similarly advises people who are constipated to raise their water and fiber intake and to move more.
What people report
In online communities, people on GLP-1 medicines talk about carrying a water bottle, setting phone reminders to drink, adding electrolyte powders or tablets, and using broth when solid food does not appeal. The themes people commonly describe are that thirst feels weaker, that headaches and tiredness improve when they drink more, and that constipation is worse on days they forget.
People also commonly mention that carbonated drinks make fullness worse, and that sipping is easier than drinking a large glass at once.
None of this was measured. It is here because hydration is one of the most common topics in these communities, not because any routine was tested. If you are thinking about electrolyte supplements, ask a clinician first, especially with kidney disease or blood pressure medicine.
Who needs to be careful
- Anyone vomiting, with diarrhea, or unable to keep fluids down, who should call the prescriber.
- Anyone with kidney disease or at risk of it, who may be given a specific fluid or mineral plan.
- Anyone on a water pill or blood pressure medicine, who should ask whether fluid loss changes anything for them.
- Anyone with heart failure or on a fluid limit, who should not raise fluids without asking.
Questions to bring to a clinician or dietitian
- How much should I drink given my kidneys and other medicines?
- Are electrolyte drinks or supplements safe for me?
- Which signs of dehydration should make me call?
- Should my kidney function be checked after dose increases?
What is still unknown
- How much fluid people on these medicines should drink is not set by the sources reviewed.
- Whether electrolyte supplements help or harm on these medicines is untested.
- How often dehydration leads to kidney injury in real-world use is not known, because postmarketing reports cannot give a rate.
Related pages
Sources
- Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society Mozaffarian D, et al. Obes Pillars. 2025;15:100181. PMID 40673264. Funding: Professional societies; several authors report industry relationships. Journal article
- Clinical recommendations to manage gastrointestinal adverse events in patients treated with GLP-1 receptor agonists: a multidisciplinary expert consensus Gorgojo-Martínez JJ, et al. J Clin Med. 2023;12(1):145. PMID 36614945. Funding: Not stated in the abstract. Journal article
- Wegovy (semaglutide) injection and tablets: prescribing information Novo Nordisk, on DailyMed (U.S. National Library of Medicine). Label version 6/2026. One label covers both the injection and the tablets. Official FDA label on DailyMed
- Zepbound (tirzepatide) injection: prescribing information Eli Lilly and Company, on DailyMed (U.S. National Library of Medicine). Label version 8/2026. Official FDA label on DailyMed